<DOC>
	<DOCNO>NCT01727401</DOCNO>
	<brief_summary>Fondaparinux parenteral anticoagulant drug approve prophylaxis venous thromboembolism high risk medical patient . A relevant proportion patient renal insufficiency and/or thrombocytopenia represent independent risk factor bleed . The risk bleeding may increase fondaparinux administer patient reduce renal function and/or low platelet count . A low dose fondaparinux , 1.5 mg daily , approve patient renal insufficiency define creatinine clearance 20 50 mL/min . However , knowledge , clinical study specifically evaluate prophylaxis fondaparinux acutely-ill medical patient moderate severe thrombocytopenia . The scope study evaluate safety fondaparinux high risk hospitalize medical patient moderate severe thrombocytopeniada define platelet count 100,000/uL 30,000/uL .</brief_summary>
	<brief_title>Thromboprophylaxis Venous Thromboembolism Acutely-ill Medical Inpatients With Thrombocytopenia</brief_title>
	<detailed_description />
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Thrombocytopenia</mesh_term>
	<mesh_term>Fondaparinux</mesh_term>
	<mesh_term>PENTA</mesh_term>
	<criteria>Age 18 year ; hospitalization Internal Medicine Unit Barbar score 4 point Platelet count 100,000/uL 30,000/uL write informed consent Active bleeding bleeding within previous 3 month ; Known bleed diathesis ; Active gastroduodenal ulcer ; Severe renal insufficiency define creatinine clearance 20 mL/min ; Ongoing treatment unfractionated heparin , lowmoleculrweight heparin , fondaparinux , oral anticoagulant Trattamento corso con eparina non Prophylaxis unfractionated heparin , lowmoleculrweight heparin , fondaparinux 48 hour ; double antiplatelet therapy acetylsalicylic acid daily dose 165 mg ; plan invasive procedure period thromboprophylaxis ; Hemoglobin value 9 g/dL ; AST ALT 2 time up limit normal ; pregnancy breast feeding ; life expectancy lower 1 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Fondaparinux</keyword>
	<keyword>medical patient</keyword>
	<keyword>vein thromboembolism</keyword>
	<keyword>prophylaxis</keyword>
	<keyword>thrombocytopenia</keyword>
</DOC>